The majority of in situ breast cancers are DCIS. DCIS represents a premalignant marker for invasive breast cancer risk in the ipsilateral breast, whereas LCIS confers an increased risk for the development of invasive breast cancer in both breasts. The majority of DCIS are found radiographically, ...
The majority of in situ breast cancers are DCIS. DCIS represents a premalignant marker for invasive breast cancer risk in the ipsilateral breast, whereas LCIS confers an increased risk for the development of invasive breast cancer in both breasts. The majority of DCIS are found radiographically, ...
For the above reasons, a test that is faster, cheaper and non-invasive (and potentially more culturally acceptable), for the diagnosis of both early breast cancer and for the diagnosis and monitoring of metastatic breast cancer, would be highly desirable. It would have the potential to increase...
Mammography or other X-ray methods are currently most used for detection of breast cancers. However, every time a mammogram is taken, the patient incurs a small risk of having a breast tumor induced by the ionizing radiation properties of the X-rays used during the mammogram. Also, the proce...
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. RESULTS: Six invasive breast cancers and one noninvasive breast cancer were detected among the 196 high-risk women. Five of the invasive cancers occurred ...
of death among women worldwide.Common methods for diagnosis lack the sensitivity and specificity.More sensitive biomarkers for early detection are urgently needed.Metabolomics may provide clinically useful biomarkers in breast cancer.Metabolomics methods may open new avenues for diagnostics in breast cancer...
CONTEXT: Screening ultrasound may depict small, node-negative breast cancers not seen on mammography. OBJECTIVE: To compare the diagnostic yield, defined a... Merritt,RB C. - 《Journal of the American Medical Association》 被引量: 1498发表: 2008年 Mammography, Breast Ultrasound, and Magnetic Res...
It accounts for 7 to 10 percent of all cancers, particularly among women aged 40 to 60. Women are more vulnerable before and after menopause. According to Dr Guo Qian of Shanghai No. 6 Hospital, breast tissues are ide...
N, Monville F, Gelsi-Boyer V, Esterni B, Geneix J, Finetti P, Zemmour C, Viens P, Charafe-Jauffret E, Jacquemier J, Birnbaum D, Chaffanet M: Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers....
Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway Endocrine resistance is a major challenge in the management of estrogen receptor (ER)-positive breast cancers. Although multiple mechanisms leading to endo... B Ramaswamy,Y Lu...